Association for Molecular Pathology's 15th Annual Meeting and Exhibits

November 09, 2009

WASHINGTON, DC (November 9, 2009) - The Association for Molecular Pathology (AMP) invites the media to follow its upcoming 2009 Annual Meeting and Exhibits and learn about the latest advances in clinical molecular diagnostics.

What: The four-day event will feature more than 100 corporate exhibits, as well as many cutting-edge lectures, workshops and plenary sessions. The keynote speaker is the distinguished recipient of the 2009 AMP Award for Excellence in Molecular Diagnostics, Kay E. Davies, Ph.D., of the University of Oxford. Additional presentation titles include: Who: AMP is offering complimentary registration packages for contacts from qualified print, online and broadcast news media outlets. If you are unable to attend the meeting, please contact the AMP Press Room Manager to request interviews with speakers and be added to the media distribution list.
When: November 19-22, 2009
Where: Gaylord Palms Resort & Convention Center, Kissimmee, FL

Why: Media registrants will be able to take advantage of our Press Room, as well as many new services and amenities including:
Please contact Andrew Noble if you are interested in attending this year's meeting and/or if you would like to be added to AMP's media list. For more information the 2009 Annual Meeting, please visit:

About AMP

The Association for Molecular Pathology (AMP) is an international medical professional association dedicated to the advancement, practice, and science of clinical molecular laboratory medicine and translational research based on the applications of molecular biology, genetics and genomics. For more information, please visit:

Association for Molecular Pathology

Related Molecular Diagnostics Articles from Brightsurf:

New cancer diagnostics: A glimpse into the tumor in 3D
A new technique could initiate a revolution in pathology: Tumor tissue is made transparent and illuminated with a special ultramicroscope.

'Cyborg' technology could enable new diagnostics, merger of humans and AI
Although true ''cyborgs'' are science fiction, researchers are moving toward integrating electronics with the body.

Study uses RNA sequencing as alternative to immunohistochemistry in cancer diagnostics
For the first time, researchers from the Moscow Institute of Physics and Technology and their colleagues have succeeded in using RNA sequencing as an alternative to immunohistochemistry for cancer diagnostics.

Rapid EUnetHTA assessment on coronavirus diagnostics supported by IQWiG
Rapid EUnetHTA assessment on coronavirus diagnostics supported by IQWiG. Antibody tests can detect a past infection with SARS Corona virus.

Inexpensive retinal diagnostics via smartphone
Retinal damage due to diabetes is now considered the most common cause of blindness in working-age adults.

Diagnostics, meet CRISPR
A new diagnostic test to quickly and easily monitor kidney transplant patients for infection and rejection relies on a simple urine sample and a powerful partner: the gene-editing technology CRISPR.

Cancer diagnostics
A good indicator of dysregulation in live cells is a change in their RNA expression.

New platform for cancer diagnostics and drug testing
Parts of tumor tissue, which is normally discarded in cancer surgery, bear information about the disease.

Implementing microbiome diagnostics in personalized medicine: Rise of pharmacomicrobiomics
A new Commentary identifies three actionable challenges for translating pharmacomicrobiomics to personalized medicine in 2020.

Portable MRIs bring diagnostics to stroke patients' bedside
For the first time, portable, low-field MRIs have successfully imaged patients' brains to evaluate stroke at their bedside.

Read More: Molecular Diagnostics News and Molecular Diagnostics Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to